About
Our Mission
Leadership
Partners
Our Technologies
TALEN® Technology
Gene Editing
PulseAgile Technology
Patents
Pipeline
Products
Clinical Indications
Manufacturing
Investors
Press Releases
Corporate Presentation
Scientific Presentations
Scientific Publications
Events and Webcasts
2021 Cellectis Innovation Days
Stock Information
Corporate Governance
Governance Documents
Board of Directors & Committee Members
Shareholders Meeting
SEC Filings
Contact
IR Inquiries
Email Alerts
Investor FAQ
Careers
Our Culture
Job Opportunities
Contact us
fr
Press Releases
Our latest news and press releases
Press releases
Corporate presentation
Scientific Presentations
Scientific Publications
Events and webcasts
Stock information
SEC filings
Financial Statements
Regulated information
Voting Rights & Share Capital
ATM Program
General meetings
Governance
The board and committee members
Corporate governance documents
FAQ
IR Inquiry
All
2023
2022
2021
2020
2019
2018
17
Nov 2023
16:30 E.S.T.
Cellectis’ Shareholders Meeting to be Held on December 22, 2023
Read more
15
Nov 2023
02:30 E.S.T.
Cellectis Announces the execution of the Subsequent Investment Agreement with AstraZeneca
Read more
06
Nov 2023
16:30 E.S.T.
Cellectis Reports Financial Results for Third Quarter and First Nine Months 2023
Read more
02
Nov 2023
16:30 E.S.T.
Cellectis to Present Preliminary Results of NATHALI_01 and Updated Results of the BALLI_01 Phases I Trials at the American Society of Hematology (ASH) 65th Annual Meeting
Read more
01
Nov 2023
16:30 E.S.T.
Cellectis to Report Third Quarter 2023 Financial Results on November 6, 2023
Read more
01
Nov 2023
03:00 E.S.T.
Cellectis Announces Strategic Collaboration and Investment Agreements with AstraZeneca
Read more
1
2
3
Next